Burcon Nutrascience Corporation
BRCNF
$1.69
-$0.08-4.52%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 332.70% | 186.43% | 13.02% | 101.09% | 79.40% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 332.70% | 186.43% | 13.02% | 101.09% | 79.40% |
| Cost of Revenue | 925.37% | 1,159.43% | 1,202.13% | -- | -- |
| Gross Profit | -1,557.22% | -3,983.38% | -1,175.26% | -547.02% | -268.27% |
| SG&A Expenses | -25.96% | -21.52% | -15.10% | 1.17% | 15.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 42.32% | 21.48% | 16.50% | 8.83% | 9.80% |
| Operating Income | -29.38% | -15.56% | -16.71% | -6.39% | -7.94% |
| Income Before Tax | -56.86% | -30.17% | -29.70% | -7.60% | -9.68% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -56.86% | -30.17% | -29.70% | -7.60% | -10.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -56.86% | -30.17% | -29.70% | -7.60% | -10.55% |
| EBIT | -29.38% | -15.56% | -16.71% | -6.39% | -7.94% |
| EBITDA | -17.61% | -16.27% | -16.99% | -6.10% | -7.78% |
| EPS Basic | 10.86% | 19.83% | 9.19% | 15.11% | 6.38% |
| Normalized Basic EPS | 10.88% | 19.85% | 9.21% | 15.12% | -159.29% |
| EPS Diluted | 10.86% | 19.83% | 9.19% | 15.11% | 6.38% |
| Normalized Diluted EPS | 10.88% | 19.85% | 9.21% | 15.12% | -159.29% |
| Average Basic Shares Outstanding | 73.57% | 59.51% | 44.09% | 28.84% | 18.16% |
| Average Diluted Shares Outstanding | 73.57% | 59.51% | 44.09% | 28.84% | 18.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |